Expression of Neurotensin and NT1 Receptor in Human Breast Cancer: A Potential Role in Tumor Progression

Souazé, Frédérique; Dupouy, Sandra; Viardot-Foucault, Véronique; Bruyneel, Erik; Attoub, Samir; Gespach, Christian; Gompel, Anne; Forgez, Patricia

doi:10.1158/0008-5472.can-06-0450

Cited by 122 publications

(155 citation statements)

References 43 publications

Supporting

Mentioning

148

Contrasting

Order By: Relevance

“…Further studies are needed to fully clarify the association between these results and the family of small Rho-like GTPases, including Rho, Rac, and Cdc42, that are involved in epithelial cell migration and invasion. 33 We also found that NTSR1 existed in LNCaP cells and that neurotensin, a neuroendocrine factor, induced the 21 reported that NTSR1 agonist-induced motility of breast cancer cell line MDA-MB-231 was blocked by selective inhibitors, including drugs targeting mitogen-activated protein kinase (MAPK), protein kinase C (PKC), and PLCg. They also showed that neurotensin-induced cell invasion involved the activation of matrix metalloproteinase-9 (MMP-9).…”

Section: Gelsolin-mediated Invasion Of Prostate Cancer K Hashimoto Et Almentioning

confidence: 90%

“…Several reports have shown that neurotensin and NTSR1 are implicated in the progression of pancreas, prostate, colon, and lung cancers. [20][21][22] Activation of NTSR1 is known to be involved in phosphatidyl inositol hydrolization. This pathway leads to the release of calcium ions into the cytoplasm from intracellular stores within the endoplasmic reticulum (calcium mobilization).…”

mentioning

confidence: 99%

See 1 more Smart Citation

The potential of neurotensin secreted from neuroendocrine tumor cells to promote gelsolin-mediated invasiveness of prostate adenocarcinoma cells

Hashimoto

Kyoda

Tanaka

et al. 2015

Laboratory Investigation

View full text Add to dashboard Cite

Neuroendocrine (NE) cells in prostate cancer have been shown to be associated with the progression of prostate cancer. However, little is known about the molecular basis of this association. We have previously demonstrated that NE cells promote metastasis of a human prostate cancer cell line (LNCaP) with overexpression of the gelsolin gene. The purpose of this study was to investigate the interactions between NE cells and LNCaP cells and the involvement of gelsolin in contributing to the invasive potential of LNCaP cells. In addition, we examined whether neurotensin induced gelsolin-mediated invasion. We used the NE cell line NE-CS that was established from the prostate of the LPB-Tag 12T-10 transgenic mouse. Small interfering RNA (siRNA) targeting gelsolin or not targeting it was transfected into LNCaP cells.

show abstract

Section: Gelsolin-mediated Invasion Of Prostate Cancer K Hashimoto Et Almentioning

confidence: 90%

mentioning

confidence: 99%

The potential of neurotensin secreted from neuroendocrine tumor cells to promote gelsolin-mediated invasiveness of prostate adenocarcinoma cells

Hashimoto

Kyoda

Tanaka

et al. 2015

Laboratory Investigation

View full text Add to dashboard Cite

show abstract

“…[49][50][51][52] Therefore, these types of neoplasia are potential targets for NT-polyplex transfection and open the possibility of exploring new approaches of gene therapy for cancer. …”

Section: Discussionmentioning

confidence: 99%

NT-polyplex: a new tool for therapeutic gene delivery to neuroblastoma tumors

et al. 2009

View full text Add to dashboard Cite

and 4 Molecular and Steroid hormones, Neurotensin and Tumor Progression INSERM UPMC Cdr Saint-Antoine Eq 7, Paris, France Neurotensin (NT)-polyplex is a nonviral system for the targeted gene delivery to cells that express and internalize the high-affinity NT receptor (NTSR1). In hemiparkinsonian rats, we previously demonstrated the morphological and functional recovery from dopaminergic neurodegeneration using the NT-polyplex as a vehicle to transfect a neurotrophic gene. The main objective of this work was to demonstrate the feasibility of NT-polyplex to transfect reporter or therapeutic genes into neuroblastoma tumors through the blood stream or by intratumoral injection. N1E-115 cells known to express NTSR1 were allografted into athymic mice to generate the neuroblastoma tumor model. Both routes of administration allowed the NT-polyplex to reach and transfect tumoral cells. A low transgene expression was also detected in intestinal tract cells only after the injection into the blood stream. The transfection of the thymidine kinase (HSVTK) suicide gene followed by ganciclovir (GCV) treatment decreased the size and weight of neuroblastoma tumors by 30-50% and increased apoptosis compared to controls. This study shows the potential of the NTpolyplex as specific gene-transfer system for NTSR1 cancer cells.

show abstract

“…One team showed that 91% of invasive ductal breast carcinomas were positive for NTSR 1 (16). Also, the level of expression of NTSR 1 was positively correlated with tumor size, Scarff-Bloom-Richardson grade, number of metastatic lymph nodes, recurrence, and survival (17).…”

Section: Breast Cancermentioning

confidence: 99%

Targeting Neuropeptide Receptors for Cancer Imaging and Therapy: Perspectives with Bombesin, Neurotensin, and Neuropeptide-Y Receptors

et al. 2014

View full text Add to dashboard Cite

Learning Objectives: On successful completion of this activity, participants should be able to list and discuss (1) the presence of bombesin receptors, neurotensin receptors, or neuropeptide-Y receptors in some major tumors; (2) the perspectives offered by radiolabeled peptides targeting these receptors for imaging and therapy; and (3) the choice between agonists and antagonists for tumor targeting and the relevance of various PET radionuclides for molecular imaging.Financial Disclosure: The authors of this article have indicated no relevant relationships that could be perceived as a real or apparent conflict of interest. CME Credit: SNMMI is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing education for physicians. SNMMI designates each JNM continuing education article for a maximum of 2.0 AMA PRA Category 1 Credits. Physicians should claim only credit commensurate with the extent of their participation in the activity. For CE credit, SAM, and other credit types, participants can access this activity through the SNMMI website (http://www.snmmilearningcenter.org) through October 2017.Receptors for some regulatory peptides are highly expressed in tumors. Selective radiolabeled peptides can bind with high affinity and specificity to these receptors and exhibit favorable pharmacologic and pharmacokinetic properties, making them suitable agents for imaging or targeted therapy. The success encountered with radiolabeled somatostatin analogs is probably the first of a long list, as multiple peptide receptors are now recognized as potential targets. This review focuses on 3 neuropeptide receptor systems (bombesin, neurotensin, and neuropeptide-Y) that offer high potential in the field of nuclear oncology. The underlying biology of these peptide/receptor systems, their physiologic and pathologic roles, and their differential distribution in normal and tumoral tissues are described with emphasis on breast, prostate, and lung cancers. Radiolabeled analogs that selectively target these receptors are highlighted.

show abstract

Expression of Neurotensin and NT1 Receptor in Human Breast Cancer: A Potential Role in Tumor Progression

Cited by 122 publications

References 43 publications

The potential of neurotensin secreted from neuroendocrine tumor cells to promote gelsolin-mediated invasiveness of prostate adenocarcinoma cells

The potential of neurotensin secreted from neuroendocrine tumor cells to promote gelsolin-mediated invasiveness of prostate adenocarcinoma cells

NT-polyplex: a new tool for therapeutic gene delivery to neuroblastoma tumors

Targeting Neuropeptide Receptors for Cancer Imaging and Therapy: Perspectives with Bombesin, Neurotensin, and Neuropeptide-Y Receptors

Contact Info

Product

Resources

About